moxalactam has been researched along with cefotaxime in 195 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 173 (88.72) | 18.7374 |
| 1990's | 6 (3.08) | 18.2507 |
| 2000's | 12 (6.15) | 29.6817 |
| 2010's | 4 (2.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandsch, M; Luckner, P | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
| Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
| Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
| Doi, Y; Nordmann, P; Paterson, DL; Poirel, L | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 3 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Matthias, FR; Schäfer, H | 1 |
| Bauernfeind, A; Eberlein, E; Jungwirth, R; Schweighart, S | 1 |
| Aparicio, M; Bouchet, JL; Bourdenx, JP; Demotes-Mainard, F; Dupoux, J; Potaux, L; Quentin, C; Vinçon, G | 1 |
| Bies, M; Kessler, RE; Leitner, F; Tsai, YH | 1 |
| Hasegawa, S; Hattori, R; Kinukawa, T; Matsuura, O; Ohshima, S; Ono, Y; Takeuchi, N | 1 |
| Adam, D; Naber, K; Schäfer, H | 1 |
| Durgham, SM; Ishag, AH; Shibl, AM | 1 |
| Chastagner, P; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C; Tancrede, C | 1 |
| Evagelopoulou, V; Giamarellou, H; Lelekis, M | 1 |
| Avril, JL; Donnio, PY; Lebert, P; Travert, MF | 1 |
| Drusano, G; McNamee, W; Ryan, P; Schimpff, S; Standiford, H; Tatem, B | 1 |
| Noel, GJ; Teele, DW | 1 |
| Liu, S; Meyer, RD | 1 |
| Graninger, W; Havel, MP; Horcher, E; Kurz, RW; Müller, MM | 1 |
| Matsubara, T; Mizuno, A; Nakashima, M; Takiguchi, Y; Uchida, K; Uematsu, T | 1 |
| Kakushi, H; Shike, T; Uchida, K | 2 |
| Heizmann, W; Luft, G; Werner, H | 1 |
| Johnson, JT; Yu, VL | 1 |
| Graninger, W; Havel, M; Horcher, E; Korninger, H; Kurz, R; Müller, M | 1 |
| Imanaka, M; Matsumoto, M; Ogita, S; Oka, T; Sugawa, T | 1 |
| Goi, H; Hara, T; Inouye, S; Ishii, T; Kazuno, Y; Watanabe, T | 1 |
| Androulakis, M; Giamarellou, H; Goumas, P; Petrikkos, G | 1 |
| Hosutt, JA; Lentnek, AL; McDevitt, JT; Nichols, RL; Wikler, MA | 1 |
| Asari, S; Hayashi, C; Horikawa, M; Kouda, K; Miyai, K; Tsukamoto, H | 1 |
| Carson, PB; Moritz, VA | 1 |
| Beam, TR; Cherubin, CE; Eng, RH; Pechere, JC | 1 |
| Cherubin, CE; Eng, RH | 1 |
| Howell, AW; Jorgensen, JH; Redding, JS | 1 |
| Le Noc, D; Le Noc, P; Rouhan, D | 1 |
| Bryskier, A; Le Noc, D; Le Noc, P | 2 |
| Baird, I; Bermudez, R; Lorber, B; Noble, R; Silverblatt, F; Vasquez, G; Yangco, BG | 1 |
| Cowles, LS; Johnson, JD; Raff, MJ; Reid, KH; Shields, CB | 1 |
| Charles, D; Larsen, B | 1 |
| Bitondo, CG; Burch, JM; Cruse, PA; Feliciano, DV; Gentry, LO; Jordan, GL; Mattox, KL | 1 |
| Berche, P; Gaillard, JL | 1 |
| Ma, MY; Rho, JP | 1 |
| Focht, J; Heilmann, HD; Heinrich, S; Klietmann, W | 1 |
| Adams, CR; Anderson, EL; Robinson, PA; Tu, KK | 1 |
| Chin, NX; Labthavikul, P; Neu, HC | 1 |
| Daly, JA; Gooch, WM | 1 |
| Marsh, TD | 1 |
| Bies, M; Buck, RE; Chisholm, DR; Kessler, RE; Leitner, F; Misiek, M; Price, KE; Pursiano, TA; Tsai, YH | 1 |
| Miyazawa, K; Takahashi, C | 1 |
| Barza, M; Noble, JT | 1 |
| Jones, RN | 1 |
| Chu, KW; Fan, ST; Lau, WY; Suen, HC; Wong, KK; Yiu, TF | 1 |
| Barriere, SL; Mordenti, J; Ozasa, DC | 1 |
| Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR | 1 |
| Ben Yaghlane, H; Bryskier, A; Labia, R; Morand, A | 1 |
| Kumamoto, Y; Miyamoto, S; Takatsuka, K; Tamiya, T | 1 |
| DeVito, JM; John, JF | 1 |
| Boelaert, J; Piot, P; Van Landuyt, HW; Verbist, L | 1 |
| Aber, RC; Al-Mondhiry, HA; Caputo, GM; Weitekamp, MR | 1 |
| Hammer-Uschtrin, U; Ullmann, U | 1 |
| Bayer, AS; Kim, KS; Manocchio, M | 1 |
| Bakken, JS; Hulsund, M | 1 |
| Drusano, GL; Koch, TR; Kroll, MH; Warren, JW | 1 |
| Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H | 1 |
| Bruch, HP; Döll, W; Kujath, P; Schmidt, E | 1 |
| File, TM; Salstrom, SJ; Tan, JS | 1 |
| Bansal, MB; Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H | 1 |
| Aikawa, N; Ishibiki, K | 1 |
| Drusano, GL; McNamee, W; Standiford, HC; Tatem, BA | 1 |
| Bryskier, A; Labia, R; Morand, A; Verchere-Beaur, C | 1 |
| Bégué, P; Lasfargues, G; Quinet, B; Quiniou, F; Safran, C | 1 |
| Brandstetter, G; Kratochvil, P; Krausse, R; Ullmann, U | 1 |
| Anton, PA; Butler, T; Jacobs, MR; Kemp, JA | 1 |
| Rahman, M | 1 |
| Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
| Gerding, DN; Hall, WH; Opfer, BJ | 1 |
| Durack, DT; Lang, SD | 1 |
| Baker, CN; Jones, RN; Thornsberry, C | 1 |
| Alexander, GA; Crawford, SA; Jorgensen, JH | 3 |
| Durack, DT; Edwards, DJ; Lang, SD | 1 |
| Baker, S; Livingston, R; Wise, R | 1 |
| McCracken, GH; Nelson, JD; Shelton, S | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 2 |
| Hewitt, WL; Hindler, JA; Kurtz, TO; Martin, WJ; Winston, DJ; Young, LS | 1 |
| Bryk, DA; Panwalker, AP; Trager, GM; White, GW; Zimelis, VM | 1 |
| Loock, CA; McCracken, GH; Schaad, UB; Thomas, ML | 1 |
| Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
| Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Ehret, J; Eickhoff, TC | 1 |
| Lareng, MB; Lefèvre, JC; Prère, MF | 1 |
| Durosoir, JL; Saliou, P; Thabaut, A | 1 |
| Eley, A; Greenwood, D; O'Grady, F; Pearson, N | 1 |
| Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C | 2 |
| Bermudez, RH; Nevarez, M; Ramirez-Ronda, CH; Saavedra, S | 1 |
| Durack, DT; Perfect, JR | 2 |
| Verbist, L | 1 |
| Armengaud, M; Barza, M; Cherubin, CE; Corrado, ML; Landesman, SH; Shah, PM | 1 |
| Slack, MP | 1 |
| Fox, JM; Quall, CO; Woolfrey, BF | 1 |
| Cherubin, CE; Corrado, ML; Landesman, SH; Sierra, MF | 1 |
| Livermore, DM; Williams, JD; Williams, RJ | 1 |
| Fu, KP; Neu, HC | 1 |
| Forsgren, A | 1 |
| Baumgärtner, M; Dickgiesser, N; Müller, S; Wundt, W | 1 |
| Gootz, TD; Martin, RR; Moellering, RC; Perkins, RL; Sanders, CC; Sanders, WE; Strike, DG | 1 |
| Blaser, J; Bonetti, A; Lüthy, R; Siegenthaler, W; Simmen, H; Wise, R | 1 |
| Acar, JF; Goldstein, FW; Kitzis, MD | 1 |
| LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
| Brogard, JM; Comte, F | 1 |
| Fekety, FR; McClatchey, KD; Pierson, CL; Schaberg, DR | 1 |
| Weinstein, AJ | 1 |
| Braveny, I; Elsser, R; Machka, K | 1 |
| Grimm, L; McCracken, GH; Nelson, JD | 1 |
| Labthavikul, P; Neu, HC | 1 |
| Neu, HC | 2 |
| Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
| Klastersky, J; Lagast, H; Zinner, SH | 1 |
| Cherubin, CE; Corrado, ML; Gombert, ME; Shulman, M; Sierra, MF | 1 |
| Farrar, WE; Rotstein, C | 1 |
| Ahonkhai, VI; Cherubin, CE; Shulman, MA; Sierra, MF | 1 |
| Kawakita, J; Kawamura, N; Ohkoshi, M; Okada, K; Satake, Y | 1 |
| Peters, G; Pulverer, G | 1 |
| Aronoff, GR; Blase, DK; Connors, BA; Evan, AP; Gattone, VH; Luft, FC | 1 |
| Craig, WA; Greenfield, RA; Kurzynski, TA | 1 |
| Gillissen, G | 1 |
| Acar, JF; Goldstein, F; Gutmann, L; Kitzis, MD; Nasnas, R | 1 |
| Chanal, M; Cluzel, R; Glanddier, Y; Sirot, D; Sirot, J | 1 |
| Traub, WH | 1 |
| Baumgärtner, M; Grehn, M; Wundt, W | 1 |
| Drew, WL; Mintz, L | 1 |
| Ernest, KD; Magnussen, CR; Sammartino, MT | 1 |
| Gaspar, MC; Ponte, MC; Soriano, F | 1 |
| Horiuchi, N; Kanai, M; Kawakami, Y; Okimura, Y | 2 |
| Ehrenkranz, NJ; Hoffman, TA | 1 |
| Pranada, F; Pusztai-Markos, Z | 1 |
| Bergeron, MG; Simard, P | 1 |
| Dunlop, WE; Fabian, TC; Stone, HH; Strom, PR | 1 |
| Gerding, DN; Peterson, LR | 1 |
| Nightingale, CH; Quintiliani, R | 1 |
| Connor, E; Melick, C; Yogev, R | 1 |
| Denolf, BL; Lambert, AM; Pyckavet, M; Van Landuyt, HW | 1 |
| Belmega, G; Borner, K; Jendroschek, T; Kemmerich, B; Koeppe, P; Lode, H | 1 |
| Fujimoto, S; Furuta, I; Harikane, O; Hiromatsu, K; Iimori, M; Kamiki, T; Kodama, J; Kotera, K; Maejima, K; Masutani, T; Matsunaga, K; Miwatani, T; Nishimura, T; Nukina, M; Shimizu, Y; Tabuki, K; Takahashi, M; Takashima, E; Takashima, T; Takeda, Y; Tanaka, M; Yabuuchi, E; Yamanaka, K; Yoshizaki, E | 1 |
| Marks, MI | 1 |
| Bauer, D; Spohr, M; Traub, WH | 1 |
| Cluzel, R; Garnier, R; Joly, B; Sirot, D; Sirot, J | 1 |
| Alpegiani, M; Arcamone, F; Battistini, C; Bedeschi, A; Della Bruna, C; Foglio, M; Franceschi, G; Perrone, E; Sanfilippo, A; Zarini, F | 1 |
| Duez, JM; Kazmierczak, A; Kohli, E; Pechinot, A; Tremeaux, JC | 1 |
| Garzone, P; Lyon, J; Yu, VL | 1 |
| Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G | 1 |
| Jungkind, DL; Stone, LL | 1 |
| Bismuth, R; Grosset, J; Jarlier, V | 1 |
| Bryskier, A; Husson, MO; Izard, D; Leclerc, H | 1 |
| Acar, JF; Bure, A; Christol, D; Courtieu, AL; Dabernat, H; Deforges, L; Duval, J; Kitzis, D; Le Van Thoi, J; Soussy, CJ | 1 |
| Andrews, JM; Wise, R | 1 |
| Hara, K; Kanda, T; Saito, A; Sawatari, K; Toro, J | 1 |
| Knothe, H | 1 |
| Endo, Y; Fujimoto, S; Hara, M; Kohi, F; Lai, M; Oda, Y; Ohmoto, E; Takahashi, I; Takaoka, K; Uchida, K | 1 |
| Meyer, RD; Pasiecznik, K | 1 |
| Schaad, UB | 1 |
| Cohen, SH; Demling, R; Franti, CE; Gunther, R; Hoeprich, PD; Merry, JM; Miner, DJ | 1 |
| Asahi, Y; Isono, M; Kesado, T; Ueno, K; Watanabe, K | 1 |
| Jones, RN; Wilson, HW | 1 |
| Bartmann, K; Tarbuc, R | 1 |
| Andrassy, K; Fritz, S; Koderisch, J; Ritz, E | 1 |
| Jaenisch, E; Shah, PM | 1 |
| Azuma, K; Nishino, T; Saito, M; Tanino, T | 1 |
| Lewis, JC; Lipsky, JJ; Novick, WJ | 1 |
| Doroshow, CA; Drake, TA; Hackbarth, CJ; Rusnak, MG; Sande, MA; Täuber, MG | 1 |
| Calderwood, SB; Jackson, E; Tung, CC | 1 |
| Asari, S; Hayashi, C; Horikawa, M; Koda, K; Miyai, K; Shimizu, Y; Tsukamoto, H | 1 |
| Fievet, MH; Jarlier, V; Nguyen, J; Nicolas, MH; Truffot, C | 1 |
| Benno, Y; Hashimoto, S; Igimi, H; Satoh, T; Takeuchi, N; Uchida, K | 1 |
| Ahn, B; Chay, K; Jung, Y; Lee, M; Song, D; Yang, S | 1 |
8 review(s) available for moxalactam and cefotaxime
| Article | Year |
|---|---|
The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Humans; Moxalactam | 1985 |
Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cefotaxime; Ceftazidime; Gram-Positive Bacteria; Humans; Imipenem; Moxalactam; Penicillin Resistance; Penicillins; Streptococcus; Thienamycins | 1985 |
Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Blood-Brain Barrier; Cefamandole; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cephalothin; Cephamycins; Child, Preschool; Enterobacteriaceae; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Moxalactam; Pseudomonas aeruginosa | 1981 |
Antipseudomonal beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1981 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
Topics: Bacteria; Bacterial Infections; Bacteroides fragilis; Cefamandole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Humans; Moxalactam; Pseudomonas aeruginosa | 1983 |
The cephalosporin compounds in severe neonatal infection.
Topics: Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Enterobacteriaceae Infections; Humans; Infant, Newborn; Meningitis; Moxalactam; Sepsis | 1984 |
16 trial(s) available for moxalactam and cefotaxime
| Article | Year |
|---|---|
Relationship between vitamin K1 2,3-epoxide and vitamin K1 in patients treated with N-methyl-thiotetrazole cephalosporins.
Topics: Cefoperazone; Cefotaxime; Humans; Middle Aged; Moxalactam; Urinary Tract Infections; Vitamin K 1 | 1992 |
[Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
Topics: Aged; Aged, 80 and over; Azoles; Blood Coagulation Disorders; Cefoperazone; Cefotaxime; Cephalosporins; Female; Humans; Male; Moxalactam; Pilot Projects; Protein C; Prothrombin Time; Random Allocation; Tetrazoles; Urinary Tract Infections; Vitamin K Deficiency | 1989 |
Effect of cefotaxime, ceftriaxone and latamoxef on blood coagulation in patients on parenteral nutrition.
Topics: Aged; Blood Coagulation; Cefotaxime; Ceftriaxone; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Moxalactam; Parenteral Nutrition; Random Allocation | 1987 |
Antibiotic use during major head and neck surgery.
Topics: Anti-Bacterial Agents; Cefazolin; Cefoperazone; Cefotaxime; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Gentamicins; Head and Neck Neoplasms; Humans; Moxalactam; Premedication; Prospective Studies; Random Allocation | 1988 |
Effects of cephalosporins and carumonam on blood coagulation.
Topics: Blood Coagulation; Blood Coagulation Tests; Cefotaxime; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Humans; Moxalactam; Random Allocation; Structure-Activity Relationship | 1987 |
A comparative study of cefoxitin, cefotaxime, moxalactam and aztreonam kinetics in saliva.
Topics: Aztreonam; Cefotaxime; Cefoxitin; Humans; Moxalactam; Saliva | 1987 |
Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Ceftizoxime; Cephalosporins; Double-Blind Method; Female; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Prothrombin Time; Random Allocation | 1987 |
Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Cefotaxime; Ceftizoxime; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Random Allocation; Risk | 1987 |
Single agent cephalosporin prophylaxis for penetrating abdominal trauma. Results and comment on the emergence of the enterococcus.
Topics: Abdominal Injuries; Adult; Cefotaxime; Cefoxitin; Drug Evaluation; Female; Humans; Male; Moxalactam; Postoperative Complications; Prospective Studies; Random Allocation; Wound Infection; Wounds and Injuries | 1986 |
Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis.
Topics: Anti-Bacterial Agents; Appendectomy; Cefoperazone; Cefotaxime; Child; Clinical Trials as Topic; Double-Blind Method; Humans; Kinetics; Moxalactam; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection | 1985 |
The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers.
Topics: Blood Coagulation; Blood Platelets; Cefoperazone; Cefotaxime; Humans; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time | 1985 |
[Perioperative prophylaxis in elective colorectal surgery].
Topics: Aged; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Colonic Neoplasms; Combined Modality Therapy; Crohn Disease; Diverticulitis, Colonic; Humans; Intestinal Mucosa; Mezlocillin; Middle Aged; Moxalactam; Piperacillin; Premedication; Rectal Neoplasms; Surgical Wound Infection | 1984 |
Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Humans; Kinetics; Male; Moxalactam; Stereoisomerism; Time Factors | 1981 |
Third-generation cephalosporins for polymicrobial surgical sepsis.
Topics: Abscess; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Peritonitis; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1983 |
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Moxalactam | 1983 |
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections | 1983 |
171 other study(ies) available for moxalactam and cefotaxime
| Article | Year |
|---|---|
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefozopran; Cefpirome; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
Pharmacokinetic considerations for treatment of bacterial peritonitis during continuous ambulatory peritoneal dialysis.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Female; Fosfomycin; Humans; Male; Middle Aged; Moxalactam; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.
Topics: Animals; Animals, Newborn; Bacteria; Cefepime; Cefotaxime; Cephalosporins; Male; Meningitis; Mice; Microbial Sensitivity Tests; Moxalactam; Rats; Rats, Inbred Strains | 1990 |
[A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
Topics: Aged; Aged, 80 and over; Biological Transport; Cefoperazone; Cefotaxime; Chromatography, High Pressure Liquid; Humans; Male; Middle Aged; Moxalactam; Premedication; Prostate; Prostatectomy; Prostatic Hyperplasia | 1986 |
Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Topics: Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Cross Infection; Gentamicins; Gram-Negative Bacteria; Moxalactam; Ticarcillin | 1989 |
Role of parenteral antibiotherapy in gastrointestinal tract flora suppression. A study in children treated with high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adolescent; Agranulocytosis; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Digestive System; Dose-Response Relationship, Drug; Drug Combinations; Feces; Female; Gentamicins; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Male; Mezlocillin; Moxalactam; Sulfamethizole; Suppression, Genetic; Tobramycin; Transplantation, Autologous; Trimethoprim | 1989 |
Enhanced in-vitro bactericidal activity of amikacin combined with latamoxef, cefotaxime and aztreonam against multi-resistant Enterobacter cloacae.
Topics: Amikacin; Aztreonam; beta-Lactamases; Cefotaxime; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Time Factors | 1989 |
[Action of imipenem on Enterobacter cloacae].
Topics: Cefotaxime; Cefoxitin; Ceftazidime; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Imipenem; Moxalactam; Penicillin Resistance; Phenotype; Piperacillin; Thienamycins | 1988 |
Correlation of predicted serum bactericidal activities and values measured in volunteers.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Drug Evaluation; Escherichia coli; Humans; Klebsiella pneumoniae; Male; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus | 1986 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
Determination of the effect of antimicrobics in combination against Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefotaxime; Drug Combinations; Drug Synergism; Erythromycin; Gentamicins; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Moxalactam; Penicillin G; Rifampin; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
Topics: Adenosine Diphosphate; Adult; Animals; Anti-Bacterial Agents; Blood Coagulation; Cefaclor; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalexin; Cephalosporins; Collagen; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Effects of 1-S replaced and/or decarboxylated latamoxef on rabbit platelet aggregation in vitro.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Carbenicillin; Cefmetazole; Cefotaxime; Cephamycins; In Vitro Techniques; Male; Moxalactam; Platelet Aggregation; Rabbits | 1988 |
In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefotaxime; Cefoxitin; Cephalosporins; Clindamycin; Clostridium; Moxalactam; Peptococcaceae; Propionibacterium acnes | 1988 |
Transcervical amnioinfusion of antibiotics: a basic study for managing premature rupture of membranes.
Topics: Amnion; Anti-Bacterial Agents; Catheterization; Cefoperazone; Cefotaxime; Cervix Uteri; Chorioamnionitis; Female; Fetal Membranes, Premature Rupture; Humans; Moxalactam; Pregnancy | 1988 |
[Antibacterial activity of cefminox in human urine].
Topics: Bacteria; Cefotaxime; Cephamycins; Humans; In Vitro Techniques; Moxalactam; Urine | 1988 |
Effect of latamoxef (moxalactam) and its related compounds on platelet aggregation in vitro--structure activity relationships.
Topics: Adenosine Diphosphate; Carbenicillin; Cefotaxime; Ceftizoxime; Collagen; Humans; In Vitro Techniques; Male; Moxalactam; Platelet Aggregation; Structure-Activity Relationship | 1987 |
[Susceptibility of clinical isolates to aztreonam].
Topics: Aztreonam; Cefmetazole; Cefoperazone; Cefotaxime; Cefsulodin; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1987 |
Cefoxitin sensitivity as a marker for inducible beta-lactamases.
Topics: beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Gram-Negative Bacteria; Microbial Sensitivity Tests; Moxalactam; Pseudomonas | 1986 |
Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp.
Topics: Adult; beta-Lactamases; Cefotaxime; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Male; Meningitis; Middle Aged; Moxalactam; Serratia | 1987 |
Experience with the use of cefotaxime in the treatment of bacterial meningitis.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1986 |
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroidaceae; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Ceftizoxime; Clostridium; Evaluation Studies as Topic; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1986 |
[In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
Topics: Cefmenoxime; Cefotaxime; Ceftazidime; Ceftriaxone; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Moxalactam; Phenotype | 1986 |
[In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
Topics: Bacteria; Cefotaxime; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Microbial Sensitivity Tests; Moxalactam | 1986 |
Effect of the topical application of some newer antibiotics on the cerebral cortex.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cats; Cefoperazone; Cefotaxime; Cerebral Cortex; Metronidazole; Moxalactam; Piperacillin | 1987 |
Pharmacokinetics of cefotaxime, moxalactam, and cefoperazone in the early puerperium.
Topics: Adult; Cefoperazone; Cefotaxime; Female; Humans; Injections, Intravenous; Kinetics; Moxalactam; Postpartum Period; Pregnancy | 1986 |
[In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Topics: Cefotaxime; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Moxalactam; Species Specificity | 1986 |
The effect of control on the pattern of utilization of cefotaxime, moxalactam and cefoperazone in a teaching hospital.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Hospitals, Teaching; Humans; Medical Records; Moxalactam; Pharmacy Service, Hospital; Premedication; Retrospective Studies | 1985 |
A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibiotics.
Topics: Bacterial Infections; Cefotaxime; Humans; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1985 |
Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Ceftriaxone; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephamycins; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1985 |
In vitro antibacterial activity of SK&F 88070 against aerobic gram-positive and gram-negative cocci and Haemophilus influenzae.
Topics: Ampicillin; Cefmenoxime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Methicillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biological Availability; Blood Proteins; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Mice; Microbial Sensitivity Tests; Moxalactam; Protein Binding | 1985 |
[Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
Topics: Ampicillin; Cefazolin; Cefmenoxime; Cefmetazole; Cefotaxime; Cephamycins; Escherichia coli; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Proteus; Proteus mirabilis; Serratia marcescens | 1985 |
Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?
Topics: Bile; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Half-Life; Humans; Kinetics; Moxalactam | 1985 |
Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
Topics: Adult; Anti-Bacterial Agents; Bacillus subtilis; Cefoperazone; Cefotaxime; Ceftizoxime; Escherichia coli; Female; Humans; Male; Moxalactam; Staphylococcus aureus | 1985 |
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1985 |
Behaviour of cefmenoxime towards beta-lactamases.
Topics: beta-Lactamases; Cefmenoxime; Cefotaxime; Cefoxitin; Computers; Enterobacter; Escherichia coli; Kinetics; Klebsiella; Moxalactam; Proteus vulgaris; Pseudomonas aeruginosa | 1985 |
Effects of MT-141, a new cephamycin antibiotic, on acute urinary tract infections.
Topics: Adult; Aged; Cefotaxime; Cephamycins; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Urinary Tract Infections | 1985 |
Effect of formulary restriction of cefotaxime usage.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoperazone; Cefotaxime; Child; Child, Preschool; Drug Utilization; Female; Formularies, Hospital as Topic; Humans; Infant; Male; Medicine; Middle Aged; Moxalactam; Retrospective Studies; Specialization; Specialties, Surgical | 1985 |
In vitro activity of temocillin against clinical isolates.
Topics: Bacteria; Cefotaxime; Cefuroxime; Cephalothin; Gram-Positive Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1985 |
Influence of cefmenoxime, ceftriaxone, latamoxef, and ceftazidime on the lysis of Klebsiella pneumoniae: a light and electron microscopic study.
Topics: Bacteriolysis; Cefmenoxime; Cefotaxime; Ceftazidime; Ceftriaxone; Cell Wall; Culture Media; Klebsiella pneumoniae; L Cells; Microscopy, Electron; Microscopy, Phase-Contrast; Moxalactam; Staining and Labeling | 1984 |
Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
Topics: Animals; Animals, Newborn; Blood Bactericidal Activity; Cefotaxime; Escherichia coli Infections; Female; Meningitis; Microbial Sensitivity Tests; Moxalactam; Rats; Rats, Inbred Strains; Sepsis | 1984 |
New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Humans; Moxalactam; Tobramycin | 1984 |
Lack of interference with creatinine assays by four cephalosporin-like antibiotics.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Creatinine; False Positive Reactions; Humans; Moxalactam | 1984 |
In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefazolin; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1984 |
Diffusibility of the newer cephalosporins into human interstitial fluids.
Topics: Adolescent; Adult; Blood Proteins; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Diffusion; Extracellular Space; Humans; Male; Middle Aged; Moxalactam; Protein Binding | 1984 |
Newer beta-lactam antibiotics in the treatment of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Rabbits; Staphylococcal Infections | 1984 |
[The third generation cephems for surgical infections].
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftizoxime; Drug Evaluation; Humans; Moxalactam; Surgical Wound Infection | 1984 |
The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
Topics: Adolescent; Adult; Bacteria; Cefoperazone; Cefotaxime; Humans; Male; Microbial Sensitivity Tests; Moxalactam; Neutropenia | 1984 |
Affinity of cefmenoxime for beta-lactamases: an analysis.
Topics: Bacteria; beta-Lactamases; Cefmenoxime; Cefotaxime; Cephalosporinase; Cephalosporins; Hydrolysis; Kinetics; Moxalactam; Penicillinase | 1984 |
Comparative pharmacokinetics of four new cephalosporins: moxalactam, cefotaxime, cefoperazone and ceftazidime in neonates.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Moxalactam | 1984 |
Investigation of human bile and serum levels by high pressure liquid chromatography after administration of latamoxef or cefotaxime.
Topics: Aged; Bile; Cefotaxime; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Moxalactam; Stereoisomerism | 1984 |
Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection.
Topics: Ampicillin; Animals; Cefotaxime; Ceftriaxone; Female; Mice; Microbial Sensitivity Tests; Moxalactam; Salmonella Infections, Animal; Salmonella typhimurium; Spleen | 1982 |
Activities of two aminoglycosides and five newer beta-lactam antibiotics: safer alternatives to aminoglycosides?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Humans; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Tobramycin | 1984 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Staphylococcus; Streptococcus; Ticarcillin | 1980 |
In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Lactams; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins | 1980 |
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Topics: Azlocillin; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1980 |
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
Topics: Anaerobiosis; Bacteria; Bacteroides; Carbenicillin; Cefotaxime; Cephalosporins; Cephamycins; Clostridium; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1980 |
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Topics: Aerobiosis; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Fermentation; Microbial Sensitivity Tests; Moxalactam; Pseudomonas | 1980 |
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Topics: Aerobiosis; Bacteria; Blood; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Culture Media; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus | 1980 |
In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
Topics: Ampicillin; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Moxalactam; Penicillin Resistance; Species Specificity | 1980 |
Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.
Topics: Adult; Blister; Body Fluids; Cefotaxime; Cephalosporins; Cephamycins; Escherichia coli; Humans; Kinetics; Male; Moxalactam | 1980 |
In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins.
Topics: Bacteria; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Drug Resistance, Microbial; Humans; Moxalactam | 1980 |
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1980 |
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Topics: Aminoglycosides; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
Topics: Bacteria; Cefoperazone; Cefotaxime; Cephalosporinase; Cephalosporins; Cephamycins; Drug Interactions; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Moxalactam | 1981 |
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
Topics: Ampicillin; Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Escherichia coli; Humans; Kinetics; Listeria monocytogenes; Male; Meningitis; Moxalactam; Penicillin Resistance; Rabbits; Streptococcus agalactiae | 1981 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam | 1981 |
Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Topics: Bacteria; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Moxalactam | 1981 |
Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
Topics: Ampicillin; Cefazolin; Cefotaxime; Cefotiam; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Cephamycins; Female; France; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillins | 1981 |
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Topics: Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Neisseria meningitidis | 1981 |
In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
Topics: Ampicillin; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Time Factors | 1981 |
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Moxalactam | 1981 |
Comparative in-vitro activity of moxalactam and cefotaxime against isolates from blood culture.
Topics: Bacteria; Blood; Cefotaxime; Cephalosporins; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis; Moxalactam; Rabbits; Sulfamethoxazole; Trimethoprim | 1981 |
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Enterobacteriaceae Infections; Fermentation; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
New drugs for enteric gram-negative bacillary meningitis in adults.
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Meningitis; Meningitis, Haemophilus; Moxalactam | 1981 |
Potential value of cefoperazone in bacterial meningitis: experimental studies.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis, Haemophilus; Moxalactam; Rabbits | 1981 |
Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Topics: Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Ticarcillin | 1981 |
Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
Topics: Ampicillin; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Humans; Moxalactam; Penicillin G; Penicillin Resistance; Streptococcal Infections; Streptococcus agalactiae | 1981 |
Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa | 1981 |
Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
Topics: Bacteroides fragilis; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Cephamycins; In Vitro Techniques; Moxalactam | 1981 |
Comparative in vitro activity of first, second and third generation cephalosporins.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Structure-Activity Relationship | 1981 |
[Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Topics: Bacteria; Cefazolin; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1981 |
Resistance to cefamandole: a collaborative study of emerging clinical problems.
Topics: Adult; Aged; Bacteroides Infections; beta-Lactamases; Cefamandole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Isoelectric Focusing; Male; Middle Aged; Moxalactam; Penicillin Resistance; Penicillins | 1982 |
In-vitro activity of SQ 26,776 against multiply-resistant enterobacteria--preliminary results.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Lactams; Moxalactam | 1981 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephamycins; Humans; Imipenem; Lactams; Methicillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance | 1982 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Infusions, Parenteral; Kinetics; Male; Meningitis, Haemophilus; Meningitis, Pneumococcal; Moxalactam; Rabbits; Streptococcus pneumoniae | 1982 |
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1982 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Culture Media; Humans; Injections, Intravenous; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1981 |
Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 1981 |
Resistance of Listeria to cefotaxime and moxalactam.
Topics: Cefotaxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Listeriosis; Moxalactam | 1982 |
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Listeria monocytogenes; Moxalactam; Yersinia | 1982 |
[Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Topics: Bacteria; Cefazolin; Cefmenoxime; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Gentamicins; Moxalactam; Structure-Activity Relationship | 1982 |
[Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Moxalactam | 1982 |
Effects of moxalactam and cefotaxime on rabbit renal tissue.
Topics: Acetylglucosaminidase; Animals; Cefotaxime; Cephalosporins; Cephamycins; Creatine; Kidney; Kidney Glomerulus; Male; Moxalactam; Rabbits | 1982 |
In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Clostridium; Microbial Sensitivity Tests; Moxalactam | 1982 |
Non-specific influence of antibiotics on the course of infectious processes.
Topics: Animals; Anti-Bacterial Agents; Antibody Formation; Candidiasis; Cefotaxime; Cefoxitin; Cephamycins; Cyclophosphamide; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Infections; Male; Mice; Mice, Inbred BALB C; Moxalactam; Theophylline | 1982 |
[Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Topics: Acinetobacter; Bacteria; Bacteroides fragilis; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Providencia; Pseudomonas aeruginosa | 1982 |
[Statistical regression analysis for four new cephalosporins (author's transl)].
Topics: Bacteria; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam; Regression Analysis | 1982 |
Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
Topics: Azlocillin; Cefotaxime; Cefsulodin; Cephalosporins; Cephamycins; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1982 |
[Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Topics: Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Gentamicins; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1981 |
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
The in vitro responses of Bacteroides fragilis to Moxalactam, Cefotaxime, Cefmetazole, Josamycin and erythromycin.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefmetazole; Cefotaxime; Cephamycins; Erythromycin; Leucomycins; Microbial Sensitivity Tests; Moxalactam | 1982 |
In vitro activity of cefotaxime, ceftizoxime, cefmenoxime, and latamoxef in comparison with other beta-lactam antibiotics against recent clinical isolates of Haemophilus influenzae and Haemophilus parainfluenzae.
Topics: Ampicillin; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Ceftizoxime; Cephamycins; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moxalactam | 1982 |
The newest cephalosporins: how to use them?
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Moxalactam | 1982 |
[Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1982 |
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins | 1982 |
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Cephamycins; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative tissue and extravascular fluid concentrations of ceftizoxime.
Topics: Animals; Anti-Bacterial Agents; Bile; Biliary Tract; Body Fluids; Cefazolin; Cefotaxime; Ceftizoxime; Cephamycins; Diffusion; Humans; Moxalactam; Pleural Effusion; Rabbits; Time Factors; Tissue Distribution | 1982 |
Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.
Topics: Adolescent; Adult; Aged; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Cephamycins; Humans; Kinetics; Middle Aged; Models, Biological; Moxalactam; Myelography; Protein Binding; Time Factors | 1982 |
In-vitro and in-vivo efficacy of ceftriaxone, moxalactam, and chloramphenicol against Haemophilus influenzae type b.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Chloramphenicol; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Rats | 1982 |
The in vitro activity of ceftazidime against resistant clinical isolates.
Topics: Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1983 |
[The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Topics: Bacteria; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacter; Haemophilus influenzae; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Proteus; Streptococcus pneumoniae | 1983 |
Ceftriaxone--and more to come.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Humans; Microbial Sensitivity Tests; Moxalactam | 1983 |
Plasmid-independent resistance of 'gray' colony variants of a strain of Serratia marcescens resistant to amikacin, cefotaxime and lamoxactam.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephamycins; Culture Media; DNA, Bacterial; Drug Resistance, Microbial; Moxalactam; Plasmids; Serratia marcescens | 1983 |
[In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Enterobacteriaceae; Moxalactam | 1983 |
Synthesis and biological properties of sodium (5R, 6S, 8R)-6 alpha-hydroxyethyl-2-carbamoyloxymethyl-2-penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891.
Topics: Administration, Oral; Animals; Cefotaxime; Cephalosporins; Cephamycins; Indicators and Reagents; Injections, Intravenous; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Moxalactam; Structure-Activity Relationship | 1983 |
[In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
Topics: beta-Lactamases; Cefotaxime; Cephalosporinase; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Hydrolysis; Moxalactam | 1983 |
False-susceptible results from the MS-2 system used for testing resistant Pseudomonas aeruginosa against two third-generation cephalosporins, moxalactam and cefotaxime.
Topics: Cefotaxime; Drug Resistance, Microbial; False Negative Reactions; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1983 |
[Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Moxalactam; Phenotype | 1983 |
[In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
Topics: Bacteria; Cefmenoxime; Cefotaxime; Cephalosporinase; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam | 1983 |
[In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Topics: Anti-Bacterial Agents; Bacteria; Cefmenoxime; Cefotaxime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Moxalactam | 1983 |
[In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
Topics: Bacteria; Cefotaxime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Staphylococcus aureus | 1983 |
A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.
Topics: Adult; Blister; Cefotaxime; Ceftriaxone; Half-Life; Humans; Kinetics; Male; Moxalactam | 1983 |
New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila.
Topics: Animals; Cefotaxime; Cefotiam; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Erythromycin; Guinea Pigs; Legionnaires' Disease; Moxalactam | 1983 |
[In-vitro activity of cefotaxime].
Topics: Cefotaxime; Cefoxitin; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus | 1983 |
[Clinical effects of ceftizoxime and latamoxef on infections in acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Ceftizoxime; Drug Evaluation; Female; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Moxalactam; Neutrophils | 1983 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Topics: Acinetobacter; Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cell Membrane Permeability; Drug Resistance, Microbial; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Neisseria; Pseudomonas; Staphylococcus aureus; Streptococcus | 1983 |
Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporinase; Gram-Negative Bacteria; Moxalactam; Penicillinase; Piperacillin | 1983 |
Entry of four cephalosporins into the ovine lung.
Topics: Albumins; Animals; Binding, Competitive; Blood Proteins; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Female; Humans; Lung; Lymph; Moxalactam; Proteins; Sheep | 1984 |
Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamases; Cefmetazole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1984 |
Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Cefotetan; Cefoxitin; Ceftriaxone; Cell Membrane Permeability; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1983 |
In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
Topics: Cefazolin; Cefotaxime; Enterobacteriaceae; Gram-Negative Bacteria; Haemophilus; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Species Specificity | 1983 |
New beta-lactam antibiotics and hemorrhagic diathesis: comparison of moxalactam and cefotaxime.
Topics: Adolescent; Adult; Aged; Bleeding Time; Blood Coagulation Tests; Cefotaxime; Dose-Response Relationship, Drug; Hemorrhagic Disorders; Humans; Kidney Function Tests; Middle Aged; Moxalactam; Platelet Function Tests | 1983 |
Activity of third-generation cephalosporins in human blood.
Topics: Cefotaxime; Cefotetan; Ceftriaxone; Cephamycins; Escherichia coli; Humans; Moxalactam | 1983 |
[Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotetan; Cefsulodin; Cephalosporins; Cephamycins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Kanamycin; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1983 |
Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats.
Topics: Administration, Oral; Animals; Azoles; Cefotaxime; Female; Hypoprothrombinemias; Injections, Intravenous; Moxalactam; Prothrombin Time; Rats; Rats, Inbred Strains; Tetrazoles; Vitamin K Deficiency | 1984 |
Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Ceftriaxone; Meningitis, Pneumococcal; Moxalactam; Penicillin G; Rabbits; Streptococcus pneumoniae | 1984 |
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin | 1984 |
[Susceptibility of clinical isolates to cefotaxime. Comparison to new antibiotics latamoxef, cefoperazone, and ceftizoxime].
Topics: Bacteria; Cefoperazone; Cefotaxime; Ceftizoxime; Drug Resistance, Microbial; Moxalactam; Sputum; Suppuration; Urine | 1984 |
[Resistance of Enterobacteria to cefotaxime and lamoxactam at the Pitié-Salpêtrière Hospital in 1982].
Topics: Cefotaxime; Drug Resistance, Microbial; Enterobacteriaceae; Hospitals, General; Humans; Moxalactam; Paris; Time Factors | 1984 |
Effects of beta-lactam antibiotics on intestinal microflora and bile acid metabolism in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bile; Bile Acids and Salts; Cefotaxime; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Diet; Feces; Intestines; Liver; Male; Moxalactam; Organ Size; Rats; Rats, Wistar; Weight Gain | 1996 |
Protein carbonyl formation in blood plasma by cephalosporins.
Topics: Antioxidants; Ascorbic Acid; Blood Proteins; Cefotaxime; Cephalosporins; Chelating Agents; Cysteine; Glutathione; Humans; Metals; Moxalactam; Oxidation-Reduction | 1997 |
Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Drug Resistance, Bacterial; Gram-Negative Aerobic Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxalactam; Staphylococcus | 1981 |